课题基金 / 基金详情

High-Throughput Identification of Mycobacterium tuberculosis Persistence Mechanis

High-Throughput Identification of Mycobacterium tuberculosis Persistence Mechanis
结核分枝杆菌持续机制的高通量鉴定
批准号:
8566012
负责人:
Anna DeGraff Tischler
金额:
$222.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-24 至 2018-06-30

项目摘要

项目成果

Anna DeGraff Tischler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (Mtb), the causative agent of the pulmonary infection tuberculosis, has evaded eradication from the human population due to its extraordinary ability to both persist in latently infected individuals and to generate antibiotic-tolerant persister cells. We hypothesize that different molecular mechanisms account for these two types of Mtb persistence and propose novel high-throughput genetic screens to identify and characterize these mechanisms. We will use a new technology, Tn-seq, that simultaneously identifies and quantifies transposon (Tn) insertion mutants within large random Tn mutant pools by massively parallel sequencing of Tn-genome junctions. Tn-seq has previously been used to analyze fitness of bacterial Tn mutants in various culture conditions in vitro and in some animal infection models in vivo. But Tn-seq has limited utility for studying growth conditions or infection models in which there are narrow colonization bottlenecks. We propose to adapt the Tn-seq method using bar-code sequence tags and multi-plexing to enable cost-effective analysis of smaller Tn mutant pools. We will use Tn-seq combined with infection of genetically modified mice to define on a genome- wide scale the factors that Mtb requires for persistence in the face of specific host adaptive immune defenses. We will additionally use an in vitro antibiotic selection strategy combined with Tn-seq to define factors that Mtb requires for optimal formation of antibiotic-tolerant persister cells. Ultimately, we will expand these results o relevant animal infection models, to demonstrate that the Mtb persistence factors we identify are viable drug targets. Therapeutics targeting these persistence factors would represent novel approaches to tuberculosis control that would sensitize Mtb either to natural host immune defenses or to existing antibiotics.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00294-016-0604-4
发表时间: 2016-11
期刊: CURRENT GENETICS
影响因子: 2.5
作者: [Elliott, Sarah R., Tischler, Anna D.]
通讯作者: Tischler, Anna D.
DOI: 10.1111/mmi.13332
发表时间: 2016-05
期刊: Molecular microbiology
影响因子: 3.6
作者: [Elliott SR, Tischler AD]
通讯作者: Tischler AD
DOI: 10.1128/mbio.00778-18
发表时间: 2018-06-12
期刊: mBio
影响因子: 6.4
作者: [White DW, Elliott SR, Odean E, Bemis LT, Tischler AD]
通讯作者: Tischler AD
PPE Export by the Essential ESX-5 Secretion System in M. tuberculosis Virulence
  • 批准号:
    10439881
  • 项目类别:
  • 资助金额:
    $19.38万
  • 财政年份:
    2021
  • 负责人:
    Anna DeGraff Tischler
  • 依托单位:
PPE Export by the Essential ESX-5 Secretion System in M. tuberculosis Virulence
  • 批准号:
    10286476
  • 项目类别:
  • 资助金额:
    $23.25万
  • 财政年份:
    2021
  • 负责人:
    Anna DeGraff Tischler
  • 依托单位:
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion
  • 批准号:
    10493351
  • 项目类别:
  • 资助金额:
    $19.38万
  • 财政年份:
    2021
  • 负责人:
    Anna DeGraff Tischler
  • 依托单位:
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion
  • 批准号:
    10372365
  • 项目类别:
  • 资助金额:
    $23.25万
  • 财政年份:
    2021
  • 负责人:
    Anna DeGraff Tischler
  • 依托单位:
海外基金